High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy

European Journal of Clinical Investigation

Volumn 38, Issue 9, 2008, Pages 686-692

  Garcia Gomez C ^a   Nolla, J M ^a   Valverde, J ^a   Narvaez J ^a   Corbella, E ^a   Pinto X ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Glucocorticoid; HDL cholesterol; Lipids; Lipoproteins; Rheumatoid arthritis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; DEFLAZACORT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; PREDNISONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF REPORT; STRUCTURED INTERVIEW; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIRHEUMATIC AGENTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTHRITIS, RHEUMATOID; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; LIPID METABOLISM; LIPIDS; MIDDLE AGED; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 49749096364     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.01994.x     Document Type: Article

References (39)

1. Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2007 46 : 350 7.
2. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005 35 : 8 17.
3. Kaplan MJ. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2006 18 : 289 97.
4. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003 107 : 1303 7.
5. Soubrier M, Zerkak D, Dougados M. Indications for lowering LDL Cholesterol in Rheumatoid Arthritis: an unrecognized problem. J Rheumatol 2006 33 : 1766 9.
6. Moreland LW, O'Dell JR. Glucocorticoids and rheumatoid arthritis: back to the future? Arthritis Rheum 2002 46 : 2553 63.
7. Choi HK, Seeger JD. Lipid profiles among US elderly with untreated rheumatoid arthritis. The third national health and nutrition examination survey. J Rheumatol 2005 32 : 2311 6.
8. Park Y-B, Choi HK, Kim M-Y, Lee W-K, Song J, Kim D-K et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002 113 : 188 93.
9. Maxwell SR, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994 70 : 863 70.
10. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C et al. Cardiovascular risk factors and common carotid artery calibre and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003 88 : 2527 33.
11. Ettinger WH, Klinefelter HF, Kwiterovitch PO. Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis 1987 63 : 167 72.
12. Salazar A, Mana J, Pinto X, Argimon JM, Hurtado I, Pujol R. Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia. Clin Chim Acta 2002 320 : 59 64.
13. Bruce IN. 'Not only. but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 2005 44 : 1492 502.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 34.
15. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995 38 : 44 8.
16. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980 23 : 137 45.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
19. Ettinger WH Jr., Hazzard WR. Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus. J Clin Endocrinol Metab 1988 67 : 425 8.
20. Henkin Y, Como JA, Oberman A. Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice. JAMA 1992 267 : 961 8.
21. Leong KH, Koh ET, Feng PH, Boey ML. Lipid profiles in patients with systemic lupus erythematosus. J Rheumatol 1994 21 : 1264 7.
22. Ettinger WH Jr., Hazzard WR. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 1988 37 : 1055 8.
23. Taskinen MR, Kuusi T, Yki-Jarvinen H, Nikkila EA. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidaemic healthy men. J Clin Endocrinol Metab 1988 67 : 291 9.
24. Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003 62 : 842 5.
25. MacGregor AJ, Dhilon VB, Binder A, Forte CA, Knight BC, Betteridge DJ et al. Fasting lipids and anticadiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis 1992 51 : 152 5.
26. Ewart HS, Carroll R, Severson DL. Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone. Biochem J 1997 327 : 439 42.
27. Dolinsky VW, Douglas DN, Lehner R, Vance DE. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Biochem J 2004 378 : 967 74.
28. Berg AL, Nilsson-Ehle P. Direct effects of corticotropin on plasma lipoprotein metabolism in man-studies in vivo and in vitro. Metabolism 1994 43 : 90 7.
29. Kuusi T, Saarinen P, Nikkilä EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein 2 in man. Atherosclerosis 1980 36 : 589 93.
30. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 2006 8 : R82.
31. Forrester SL, Makkar R, Shah PK. Increased high-density lipoprotein cholesterol in dyslipidemia by cholesterol ester transfer protein inhibition. An update for clinicians. Circulation 2005 111 : 1847 54.
32. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005 96 : 1221 32.
33. Imachi H, Murao K, Sayo Y, Hosokawa H, Sato M, Niimi M et al. Evidence for a potential role for HDL as an important source of cholesterol in human adrenocortical tumours via the CLA-1 pathway. Endocr J 1999 46 : 27 34.
34. Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicentre, double-blind, placebo-controlled trial. Arthritis Rheum 2005 52 : 3371 80.
35. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J et al. LA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003 114 : 647 52.
36. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003 82 : 407 13.
37. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2004 33 : 231 8.
38. Gonzalez-Gay MA. Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? Arthritis Rheum 2007 57 : 191 2.
39. Kremers HM, Reinalda MS, Crowson CS, Davis JM 3rd, Hunder GG, Gabriel SE. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum 2007 57 : 279 86.